» Articles » PMID: 22832160

Transcriptional Activation by Oct4 is Sufficient for the Maintenance and Induction of Pluripotency

Overview
Journal Cell Rep
Publisher Cell Press
Date 2012 Jul 27
PMID 22832160
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Oct4 is an essential regulator of pluripotency in vivo and in vitro in embryonic stem cells, as well as a key mediator of the reprogramming of somatic cells into induced pluripotent stem cells. It is not known whether activation and/or repression of specific genes by Oct4 is relevant to these functions. Here, we show that fusion proteins containing the coding sequence of Oct4 or Xlpou91 (the Xenopus homolog of Oct4) fused to activating regions, but not those fused to repressing regions, behave as Oct4, suppressing differentiation and promoting maintenance of undifferentiated phenotypes in vivo and in vitro. An Oct4 activation domain fusion supported embryonic stem cell self-renewal in vitro at lower concentrations than that required for Oct4 while alleviating the ordinary requirement for the cytokine LIF. At still lower levels of the fusion, LIF dependence was restored. We conclude that the necessary and sufficient function of Oct4 in promoting pluripotency is to activate specific target genes.

Citing Articles

Reconstitution of pluripotency from mouse fibroblast through Sall4 overexpression.

Xiao L, Huang Z, Wu Z, Yang Y, Zhang Z, Kumar M Nat Commun. 2024; 15(1):10787.

PMID: 39737935 PMC: 11686038. DOI: 10.1038/s41467-024-54924-5.


Redox heterogeneity in mouse embryonic stem cells individualizes cell fate decisions.

Ulfig A, Jakob U Dev Cell. 2024; 59(16):2118-2133.e8.

PMID: 39106861 PMC: 11338707. DOI: 10.1016/j.devcel.2024.07.008.


Evaluation of the Effects of Opium on the Expression of and in Wistar Rat Bladder.

Oskouie I, Zareian Baghdadabad L, Mashhadi R, Zahmatkesh P, Mirzaei A, Khajavi A Bladder Cancer. 2024; 10(1):47-59.

PMID: 38993529 PMC: 11181810. DOI: 10.3233/BLC-230076.


Epigenetic OCT4 regulatory network: stochastic analysis of cellular reprogramming.

Bruno S, Schlaeger T, Del Vecchio D NPJ Syst Biol Appl. 2024; 10(1):3.

PMID: 38184707 PMC: 10771499. DOI: 10.1038/s41540-023-00326-0.


Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts.

Ilia K, Shakiba N, Bingham T, Jones R, Kaminski M, Aravera E Sci Adv. 2023; 9(48):eadg8495.

PMID: 38019912 PMC: 10686568. DOI: 10.1126/sciadv.adg8495.


References
1.
Kim J, Chu J, Shen X, Wang J, Orkin S . An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 2008; 132(6):1049-61. PMC: 3837340. DOI: 10.1016/j.cell.2008.02.039. View

2.
Loh K, Lim B . A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell. 2011; 8(4):363-9. DOI: 10.1016/j.stem.2011.03.013. View

3.
Nichols J, Zevnik B, Anastassiadis K, Niwa H, Chambers I, Scholer H . Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998; 95(3):379-91. DOI: 10.1016/s0092-8674(00)81769-9. View

4.
Chen X, Xu H, Yuan P, Fang F, Huss M, Vega V . Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell. 2008; 133(6):1106-17. DOI: 10.1016/j.cell.2008.04.043. View

5.
Baron U, Gossen M, Bujard H . Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 1997; 25(14):2723-9. PMC: 146828. DOI: 10.1093/nar/25.14.2723. View